See more : WonderFi Technologies Inc. (WONDF) Income Statement Analysis – Financial Results
Complete financial analysis of Morgan Stanley India Investment Fund, Inc. (IIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Morgan Stanley India Investment Fund, Inc., a leading company in the Asset Management industry within the Financial Services sector.
You may be interested
- Huafon Microfibre (Shanghai) Co., Ltd. (300180.SZ) Income Statement Analysis – Financial Results
- OppFi Inc. WT (OPFI-WT) Income Statement Analysis – Financial Results
- Veea Inc. (VEEA) Income Statement Analysis – Financial Results
- Thinkific Labs Inc. (THNCF) Income Statement Analysis – Financial Results
- Okayama Paper Industries Co., Ltd. (3892.T) Income Statement Analysis – Financial Results
Morgan Stanley India Investment Fund, Inc. (IIF)
Industry: Asset Management
Sector: Financial Services
About Morgan Stanley India Investment Fund, Inc.
Morgan Stanley India Investment Fund, Inc. is a closed ended equity mutual fund launched and managed by Morgan Stanley Investment Management Inc. The fund is co-managed by Morgan Stanley Investment Management Company. It invests in the public equity markets of India. The fund invests in stocks of companies operating across diversified sectors. It benchmarks the performance of its portfolio against the U.S. dollar adjusted BSE National Index. Morgan Stanley India Investment Fund, Inc. was formed on December 22, 1993 and is domiciled in the United States.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.14M | -35.56M | 82.42M | 13.55M | -1.86M | -109.67M | 187.33M | 4.93M | 3.91M | 4.35M | 3.68M | 5.02M | 0.00 |
| Cost of Revenue | 47.75M | 3.91M | 3.99M | 3.31M | 3.78M | 5.33M | 6.56M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -45.61M | -39.48M | 78.42M | 10.24M | -5.64M | -114.99M | 180.76M | 4.93M | 3.91M | 4.35M | 3.68M | 5.02M | 0.00 |
| Gross Profit Ratio | -2,131.31% | 111.00% | 95.16% | 75.56% | 303.12% | 104.86% | 96.50% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 0.00 | -1.04 | 2.21 | -20.53 | -1.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 716.00K | 821.00K | 727.00K | 779.00K | 692.00K | 1.10M | 1.79M | 6.13M | 6.32M | 5.56M | 4.95M | 5.27M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 716.00K | 821.00K | 727.00K | 779.00K | 692.00K | 1.10M | 1.79M | 6.13M | 6.32M | 5.56M | 4.95M | 5.27M | 0.00 |
| Other Expenses | 0.00 | -139.00K | -144.00K | -105.00K | -138.00K | -215.00K | -265.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 49.89M | 682.00K | 583.00K | 674.00K | 554.00K | 889.00K | 1.52M | 14.44M | 6.59M | 136.59M | 22.18M | 94.50M | 0.00 |
| Cost & Expenses | 49.89M | 682.00K | 583.00K | 674.00K | 554.00K | 889.00K | 1.52M | 14.44M | 6.59M | 136.59M | 22.18M | 94.50M | 0.00 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 50.71M | 2.13M | 2.39M | 1.01M | -294.00K | 556.00K | 1.40M | 1.20M | 2.40M | 1.21M | 1.27M | 247.00K | 0.00 |
| EBITDA | 49.34M | -33.77M | 84.51M | 13.92M | -2.33M | -109.58M | 185.33M | 20.57M | -276.00K | 142.15M | -17.23M | 99.77M | 0.00 |
| EBITDA Ratio | 2,305.42% | 101.92% | 99.29% | 95.02% | 129.77% | 100.81% | 99.19% | 417.54% | -7.05% | 3,269.37% | -467.90% | 1,986.20% | 0.00% |
| Operating Income | -1.37M | -36.25M | 81.83M | 12.87M | -2.42M | -110.56M | 185.81M | -1.20M | -2.40M | -1.21M | -1.27M | -247.00K | 0.00 |
| Operating Income Ratio | -64.21% | 101.92% | 99.29% | 95.02% | 129.77% | 100.81% | 99.19% | -24.44% | -61.39% | -27.83% | -34.41% | -4.92% | 0.00% |
| Total Other Income/Expenses | 50.66M | -34.12M | -287.00K | 3.31M | 664.00K | 0.00 | 1.87M | 20.57M | -276.00K | 142.15M | -17.23M | 99.77M | 0.00 |
| Income Before Tax | 49.29M | -36.25M | 81.83M | 12.87M | -2.42M | -110.56M | 185.81M | 19.36M | -2.68M | 140.94M | -18.50M | 99.52M | 0.00 |
| Income Before Tax Ratio | 2,303.18% | 101.92% | 99.29% | 95.02% | 129.77% | 100.81% | 99.19% | 393.10% | -68.45% | 3,241.54% | -502.31% | 1,981.29% | 0.00% |
| Income Tax Expense | 0.00 | -2.47M | -2.67M | -1.04M | -87.00K | -161.14K | 471.00K | 20.57M | -276.00K | 142.15M | -17.23M | 99.77M | 0.00 |
| Net Income | 49.29M | -36.25M | 81.83M | 12.87M | -2.42M | -110.56M | 185.81M | 19.36M | -2.68M | 140.94M | -18.50M | 99.52M | 0.00 |
| Net Income Ratio | 2,303.18% | 101.92% | 99.29% | 95.02% | 129.77% | 100.81% | 99.19% | 393.10% | -68.45% | 3,241.54% | -502.31% | 1,981.29% | 0.00% |
| EPS | 4.96 | -3.30 | 7.29 | 1.14 | -0.18 | -8.11 | 12.96 | 1.34 | -0.18 | 9.15 | -1.16 | 5.35 | 0.00 |
| EPS Diluted | 4.96 | -3.30 | 7.29 | 1.14 | -0.18 | -7.87 | 12.96 | 1.34 | -0.18 | 9.15 | -1.16 | 5.35 | 0.00 |
| Weighted Avg Shares Out | 9.95M | 10.98M | 11.23M | 11.32M | 13.40M | 13.63M | 14.34M | 14.42M | 14.95M | 15.40M | 15.99M | 18.62M | 22.33M |
| Weighted Avg Shares Out (Dil) | 9.95M | 10.98M | 11.23M | 11.32M | 13.40M | 14.05M | 14.34M | 14.42M | 14.95M | 15.40M | 15.99M | 18.62M | 22.33M |
Cerberus Telecom Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering
Cerberus Telecom Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 25,000,000 units at $10.00 per unit.
Abbott Laboratories (ABT) Q3 2020 Earnings Call Transcript | AlphaStreet
Abbott Laboratories (NYSE: ABT) Q3 2020 earnings call dated Oct. 21, 2020
Datto's stock opens 19% above IPO price, then pulls back
Shares of Datto Holding Corp. undefined rallied out of the gate, as they opened 18.5% above the initial public offering price, before paring gains. The...
Stock market live Wednesday: Stocks slip as stimulus talks eyed, Netflix falls nearly 7%, Bitcoin rallies
This is CNBC's markets live blog that will be updated throughout the day.
Mavenir sets terms for its IPO, expects to raise up to $327 million
Mavenir PLC undefined has set terms for its initial public offering, as the Texas-based mobile networking company looks to raise up to $327.3 million. The...
JP Morgan apuesta por Europa y emergentes frente a la Bolsa de EE UU
Recomienda a sus clientes aumentar la exposición en activos de riesgo
IFM Investors Pty Ltd Increases Position in United Rentals, Inc. (NYSE:URI)
IFM Investors Pty Ltd lifted its position in United Rentals, Inc. (NYSE:URI) by 8.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 6,097 shares of the...
IFM Investors Pty Ltd Purchases 655 Shares of MongoDB, Inc. (NASDAQ:MDB)
IFM Investors Pty Ltd lifted its position in MongoDB, Inc. (NASDAQ:MDB) by 19.6% during the 3rd quarter, HoldingsChannel reports. The firm owned 4,004 shares of the company’s stock after acquiring an additional 655 shares during the quarter. IFM Investors Pty...
Dividend Changes: October 10-16, 2020
In this article series, we provide a weekly summary of dividend changes. A summary table provides relevant data and key statistics of dividend increases.
Elanco Animal Health (NYSE:ELAN) Downgraded to Sell at Zacks Investment Research
Zacks Investment Research downgraded shares of Elanco Animal Health (NYSE:ELAN) from a hold rating to a sell rating in a research note published on Tuesday, Zacks.com reports. According to Zacks, “Elanco Animal Health Incorporated operates as an animal health care...
Source: https://incomestatements.info
Category: Stock Reports